Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Seoul St. Mary's Hospital
Celgene Corporation
Information provided by (Responsible Party):
Yoo-Jin Kim, Seoul St. Mary's Hospital Identifier:
First received: July 11, 2012
Last updated: November 18, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)